← Leaderboards
Per H. Basse
University Of Pittsburgh At Pittsburgh
$3,366,449
Attributed
$3,366,449
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $491.1K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,366,449 · 6
By mechanism
P01$1,512,261 · 2
R01$1,404,177 · 2
R21$366,632 · 1
P30$83,379 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Shivendra Singh$26,555,479
- Zhou Wang$17,521,825
- Donald L Trump$24,661,732
- Albert D Donnenberg$4,266,402
- Jennifer R Grandis$109,711,044
Others in their field
Top investigators on “Natural Killer Cells”
- Barton F Haynes · Duke University$112,979,211
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Craig B Thompson · Sloan-Kettering Inst Can Research$42,638,329
- Selwyn M Vickers · University Of Alabama At Birmingham$41,029,054
- James C. Paulson · Scripps Research Institute$39,353,775
Research focus
Natural Killer CellsMelanomaNeoplasm /Cancer ImmunotherapyMalignant NeoplasmsTumorCytotoxic T LymphocyteLaboratory MouseCytokineAnimalsIn VivoKillingsNeoplastic CellInterleukin 2Tumor AntigensSitePassive ImmunizationCell TypeLungBloodImmune ResponseHmgb1 GeneAntigensIl18 GeneAdoptive Transfer
Grant awards (15)
Immune Analysis Shared Resource$83,379
P30 · FY2021 · CA · contact PI
Augmentation of NK cell-mediated anti-cancer activity by dietary BITC$199,982
R21 · FY2010 · CA · contact PI
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER$324,462
P01 · FY2009 · CA · contact PI
Augmentation of NK cell-mediated anti-cancer activity by dietary BITC$166,650
R21 · FY2009 · CA · contact PI
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER$315,180
P01 · FY2008 · CA · contact PI
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER$344,323
P01 · FY2007 · CA · contact PI
Cytokine Delivery By Tumor-Seeking Lymphocytes$222,530
R01 · FY2006 · CA · contact PI
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER$180,035
P01 · FY2006 · CA · contact PI
Cytokine Delivery By Tumor-Seeking Lymphocytes$224,996
R01 · FY2005 · CA
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER$169,039
P01 · FY2005 · CA
A New Strategy for Targeted Chemoimmunotherapy of Cancer$245,855
R01 · FY2004 · CA
Cytokine Delivery By Tumor-Seeking Lymphocytes$224,956
R01 · FY2004 · CA
A New Strategy for Targeted Chemoimmunotherapy of Cancer$248,198
R01 · FY2003 · CA
A New Strategy for Targeted Chemoimmunotherapy of Cancer$237,642
R01 · FY2002 · CA
TUMOR LOCALIZATION/THERAPEUTIC ACTIVITY OF NK CELLS IN ADOPTIVE IMMUNOTHERAPY$179,222
P01 · FY2000 · CA